CoreCap Advisors
COGT icon

CoreCap Advisors’s Cogent Biosciences COGT Stock Holding History

CoreCap Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.98K Hold
62
– – ﹤0.01% 2502
2026
Q2 		$2.4K Hold
62
– – ﹤0.01% 2494
2026
Q1 		$2.39K Hold
62
– – ﹤0.01% 2371
2025
Q4 		$2.2K Hold
62
– – ﹤0.01% 2453
2025
Q3 		$890 Hold
62
– – ﹤0.01% 2499
2025
Q2 		$445 Hold
62
– – ﹤0.01% 2530
2025
Q1 		$371 Buy
+62
New +$486 ﹤0.01% 2769

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Harbor Investment Advisory
Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

CoreCap Advisors's COGT Position: Q3 2026 in Review

CoreCap Advisors held its Cogent Biosciences (COGT) position steady in Q3 2026 at 62 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2502.

CoreCap Advisors first reported a position in COGT in Q1 2025 and has held it in 7 quarters since. The position peaked at $2.4K in Q2 2026. 26 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • CoreCap Advisors held 62 shares of Cogent Biosciences worth $1.98K as of Q3 2026.
  • CoreCap Advisors left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #2502 holding.
  • CoreCap Advisors first reported a position in Cogent Biosciences in Q1 2025 and has held it in 7 quarters since.
  • CoreCap Advisors's Cogent Biosciences position peaked at $2.4K in Q2 2026.
  • 26 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.